Difference between revisions of "Hjortkloe Manufaktur"
| Line 19: | Line 19: | ||
}} | }} | ||
| − | '''Hjortkloe Manufaktur''' (English: ''Hjortkloe Manufactory'') (Stylized as: ''HK M'') is a technological conglomerate with its roots in pre-war Sweden. '''HK M''' is driven forward by its founder's dynasty; Hjortkloe, with goals of rapid territorial as well as profitable expansion. As of current, '''Hjortkloe Manufaktur''' is under the leadership of [[Greger Hjortkloe]], sitting CEO and Company President, and its board members. | + | '''Hjortkloe Manufaktur''' (English: ''Hjortkloe Manufactory'') (Stylized as: ''HK M'') is a technological & medicinal conglomerate with its roots in pre-war Sweden. '''HK M''' is driven forward by its founder's dynasty; Hjortkloe, with goals of rapid territorial as well as profitable expansion. As of current, '''Hjortkloe Manufaktur''' is under the leadership of [[Greger Hjortkloe]], sitting CEO and Company President, and its board members. |
==Background of Hjortkloe Manufaktur== | ==Background of Hjortkloe Manufaktur== | ||
===Beginnings & The Cold War Era (1956-1990)=== | ===Beginnings & The Cold War Era (1956-1990)=== | ||
| + | During the early 1950's, a young Konstantina Hjortkloe, with her newly graduated team from Karolinska Instituted in Stockholm, consisting of doctors and physicians, were doing fieldwork and research in Korea, tending to wounded US soldiers and developing ways to fight off infections, tuberculosis and dysentery. Coming back to Sweden after the Korean War, Konstantina founded Hjortkloe Manufaktur in the town of Västervik, Northern Kalmar County. Using her experiences and research from the war, Konstantina were able to develop sophisticated vaccines that would protect people from the common ailments and infectious diseases. To the dismay and complaint of some of her colleagues, Konstantina decided to instead of issuing her results and medicines to the state, to patent her work and use it for profit. | ||
| + | |||
| + | From her institute in Västervik, Konstantina Hjortkloe made fortunes from selling large quantities of vaccines to country states and private individuals wealthy enough for the treatment. As time passed, her patents went out of use and her work became open to public access. To facilitate income, Konstantina controversially left later batches of her vaccines functional, but incomplete, which left subjects vulnerable to new strains of old diseases. People that thought themselves as immune now turned back to Hjortkloe Manufaktur for aid. Some researchers, primarily from Karolinska Institutet | ||
===Information Era & Work in the West (1991-2021)=== | ===Information Era & Work in the West (1991-2021)=== | ||
| Line 35: | Line 38: | ||
===Expansion (2121-)=== | ===Expansion (2121-)=== | ||
| + | |||
| Line 45: | Line 49: | ||
| label2 = CEO & President| data2 = Greger Hjortkloe | | label2 = CEO & President| data2 = Greger Hjortkloe | ||
| label3 = Company Heir | data3 = Jonas Hjortkloe | | label3 = Company Heir | data3 = Jonas Hjortkloe | ||
| − | | label4 = | + | | label4 = Head of Information | data4 = Veronica Harnítroca Déro |
| − | | label5 = | + | | label5 = Head of Administration | data5 = Madeleine af Säfwenquist |
| − | | label6 = | + | | label6 = Head of Public Relations | data6 = Toni Van Deijck |
| − | | label7 = | + | | label7 = Head of Technology | data7 = Alfred Au Månbåge |
| − | | label8 = | + | | label8 = Head of Medicine & Biotech. | data8 = George Folkesson |
| − | | label9 = | + | | label9 = Division Chief of Medicine| data9 = Hugo Folkesson |
| label10 = Member| data10 = Henrietta Silvferpäls | | label10 = Member| data10 = Henrietta Silvferpäls | ||
| label11 = Member| data11 = Karl Filip Törnstedt | | label11 = Member| data11 = Karl Filip Törnstedt | ||
Revision as of 04:12, 21 August 2016
 HK M, Industrial Powerhouse. | |
| Information | |
|---|---|
| Type | International Conglomerate |
| Industry | Information & Medical Technology |
| Founded | 1956, Västervik |
| Founder | Konstantina Hjortkloe |
| Contemporary | |
| Leadership |
Greger Hjortkloe (President & CEO) |
| Headquarters | Progresse, New Västervik |
| Employees | 14,800 |
Hjortkloe Manufaktur (English: Hjortkloe Manufactory) (Stylized as: HK M) is a technological & medicinal conglomerate with its roots in pre-war Sweden. HK M is driven forward by its founder's dynasty; Hjortkloe, with goals of rapid territorial as well as profitable expansion. As of current, Hjortkloe Manufaktur is under the leadership of Greger Hjortkloe, sitting CEO and Company President, and its board members.
Contents
Background of Hjortkloe Manufaktur
Beginnings & The Cold War Era (1956-1990)
During the early 1950's, a young Konstantina Hjortkloe, with her newly graduated team from Karolinska Instituted in Stockholm, consisting of doctors and physicians, were doing fieldwork and research in Korea, tending to wounded US soldiers and developing ways to fight off infections, tuberculosis and dysentery. Coming back to Sweden after the Korean War, Konstantina founded Hjortkloe Manufaktur in the town of Västervik, Northern Kalmar County. Using her experiences and research from the war, Konstantina were able to develop sophisticated vaccines that would protect people from the common ailments and infectious diseases. To the dismay and complaint of some of her colleagues, Konstantina decided to instead of issuing her results and medicines to the state, to patent her work and use it for profit.
From her institute in Västervik, Konstantina Hjortkloe made fortunes from selling large quantities of vaccines to country states and private individuals wealthy enough for the treatment. As time passed, her patents went out of use and her work became open to public access. To facilitate income, Konstantina controversially left later batches of her vaccines functional, but incomplete, which left subjects vulnerable to new strains of old diseases. People that thought themselves as immune now turned back to Hjortkloe Manufaktur for aid. Some researchers, primarily from Karolinska Institutet
Information Era & Work in the West (1991-2021)
IODS, NSM & The World at War (2022-2044)
Contemporary Hjortkloe Manufaktur
Leaving the Bunkers & Progresse (2044-2071)
Risk, Relief & Victory (2071-2121)
Expansion (2121-)
Board of Directors
| Board of Directors (2144) | |
|---|---|
| CEO & President | Greger Hjortkloe |
| Company Heir | Jonas Hjortkloe |
| Head of Information | Veronica Harnítroca Déro |
| Head of Administration | Madeleine af Säfwenquist |
| Head of Public Relations | Toni Van Deijck |
| Head of Technology | Alfred Au Månbåge |
| Head of Medicine & Biotech. | George Folkesson |
| Division Chief of Medicine | Hugo Folkesson |
| Member | Henrietta Silvferpäls |
| Member | Karl Filip Törnstedt |
| Member | Estrid Gyllengrieph |
| Member | Teresia Ehrenschöld |
